# Rosiglitazone in the Treatment of HIV-Associated Hyperlipidemia

> **NCT00006493** · PHASE2 · COMPLETED · sponsor: **National Center for Research Resources (NCRR)**

## Conditions studied

- HIV Infections
- Hyperlipidemia

## Interventions

- **DRUG:** Rosiglitazone

## Key facts

- **NCT ID:** NCT00006493
- **Lead sponsor:** National Center for Research Resources (NCRR)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006493, "Rosiglitazone in the Treatment of HIV-Associated Hyperlipidemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00006493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*